Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection
PLOS Pathogens · 30.12.2024 · 20 (12) · e1012816
DOI: 10.1371/journal.ppat.1012816 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 30.12.2024. Verfasst von Kiran Bala Sharma und 21 weiteren Autor:innen. Beteiligte Einrichtung: Regional Centre for Biotechnology, Faridabad, India. Hauptthemen laut MEDLINE: Chikungunya virus, Chikungunya Fever, Antiviral Agents, Withanolides. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, SCIENCE AND ENGINEERING RESEARCH BOARD.
Abstract (Originalsprache)
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus causing fever, myalgia, and debilitating joint swelling and pain, which in many patients becomes chronic. The frequent epidemics of CHIKV across the world pose a significant public health burden necessitating the development of effective antiviral therapeutics. A cellular imaging-based high-content screening of natural compounds identified withaferin A (WFA), a steroidal lactone isolated from the plant Withania somnifera , as a potent antiviral against CHIKV. In the ERMS cells, WFA inhibited CHIKV replication early during the life cycle by binding the CHIKV non-structural protein nsP2 and inhibiting its protease activity. This inhibited the viral polyprotein processing and the minus-sense viral RNA synthesis. WFA mounted the nsP2 protease inhibitory activity through its oxidising property as the reducing agents N-acetylcysteine and Glutathione-monoethyl ester effectively reversed the WFA-mediated protease inhibition in vitro and abolished the WFA-mediated antiviral activity in cultured cells. WFA inhibited CHIKV replication in the C57BL/6 mouse model of chikungunya disease, resulting in significantly lower viremia. Importantly, CHIKV-infected mice showed significant joint swelling which was not seen in WFA-treated mice. These data demonstrate the potential of WFA as a novel CHIKV antiviral.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Regional Centre for Biotechnology, Faridabad, India.
- Translational Health Science and Technology Institute, Faridabad, India.
- National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan.
ORCID-Profile: Sudhanshu Vrati
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- SCIENCE AND ENGINEERING RESEARCH BOARD
Zitieren
APA
Sharma, K. B., Subramani, C., Ganesh, K., Sharma, A., Basu, B., Balyan, S., Sharma, G., Ka, S., Deb, A., Srivastava, M., Chugh, S., Sehrawat, S., Bharadwaj, K., Rout, A., Sahoo, P. K., Saurav, S., Motiani, R. K., Singh, R., Jain, D., …, & Vrati, S. (2024). Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection. PLOS Pathogens, 20(12), e1012816. https://doi.org/10.1371/journal.ppat.1012816
Vancouver
Sharma KB, Subramani C, Ganesh K, Sharma A, Basu B, Balyan S, et al. Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection. PLOS Pathogens. 2024;20(12):e1012816. doi:10.1371/journal.ppat.1012816
BibTeX
@article{Sharma2024,
author = {Sharma, Kiran Bala and Subramani, Chandru and Ganesh, Khashpatika and Sharma, Anshula and Basu, Brohmomoy and Balyan, Shivani and Sharma, Ghanshyam and Ka, Shouri and Deb, Arundhati and Srivastava, Mitul and Chugh, Saurabh and Sehrawat, Sapna and Bharadwaj, Kanchan and Rout, Archana and Sahoo, Pankaj Kumar and Saurav, Suman and Motiani, Rajender K and Singh, Ramandeep and Jain, Deepti and Asthana, Shailendra and Wadhwa, Renu and Vrati, Sudhanshu},
title = {Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection},
journal = {PLOS Pathogens},
year = {2024},
volume = {20},
number = {12},
pages = {e1012816},
doi = {10.1371/journal.ppat.1012816}
}
EUVIMED